Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Quest Diagnostics
 More »

  • Quest Acquires Concentra's Toxicology, Clinical Lab Business
    Quest Diagnostics today said it has acquired the toxicology and clinical laboratory business of Humana subsidiary Concentra. Further, Quest has agreed to be Concentra's primary ...
    5-16-2013
  • Companion Diagnostics: 52 Pick-Up
    ... PrimeraDx and Quest Diagnostics Agreement announced March 26 Nonexclusive agreement to co-develop and commercialize diagnostics that will apply Primera Dx's ICEPlex System ...
    5-9-2013
  • Layoffs and Breakup at Roche
    of its Applied Science Business Area, which is part of the firm's Diagnostics Division. ... Additionally, Roche has ended of its quest to develop a nanopore-based sequencing platform ...
    4-23-2013
  • Stockholm-Uppsala Region Ups the Ante
    Area Bets Big in Quest for International Renown The ultimate goal of the Stockholm-Uppsala ... Dr. Nilsson, a professor of molecular diagnostics at Uppsala University and a member of ...
    4-15-2013
  • Thermo Fisher's (Mostly) Buying Spree
    Dionex is integrated into Thermo's Laboratory Products and Services segment. February 24, 2011 - Sells its Athena Diagnostics to Quest Diagnostics for $740 million, and its ...
    4-15-2013
  • PrimeraDx on Quest for New Companion Dx
    Molecular diagnostics company PrimeraDx has forged a nonexclusive co-development agreement with diagnostics information services company Quest Diagnostics to co-develop and ...
    3-26-2013
  • Stockholm-Uppsala Region Ups the Ante
    The region bets big in the quest for international renown. Putting neighboring-city ... Dr. Nilsson, a professor of molecular diagnostics at Uppsala University and a member of ...
    3-6-2013
  • Nucleic Acid Sample Preparation in MDx
    ... Jamie Platt, Ph.D., CGMBS, scientific director, molecular microbiology-gene sequencing, infectious diseases, Quest Diagnostics Nichols Institute, and colleagues, developed a ...
    3-1-2013
  • Duke Obtains License to Trovagene's Leukemia Dx
    of NPM1 as a laboratory service for the diagnosis and monitoring of patients with AML to Quest Diagnostics, LabCorp, Fairview Health Services, and Invivoscribe Technologies. ...
    12-27-2012
  • Epigenetics Reshapes the Therapeutic Arena
    ... In the U.S., Epigenomics has licensed its septin 9 methylation technology to Quest Diagnostics, ARUP Laboratories, and Companion Dx. "There are tens of thousands of assays that ...
    12-1-2012
  • Lucky 13 Serial Entrepreneurs
    ... magnetic resonance technology to provide rapid, accurate and portable diagnostics. ... Target Quest -Co-founder. Launched 1997 to apply phage display technology for antibody ...
    11-12-2012
  • Companion Dx and Personalized Medicine
    ... trials-to identify patients likely to benefit. "Recently, Life talked about taking technologies into CLIA labs, and has approached Quest Diagnostics and LabCorp," O'Bryan adds. ...
    11-1-2012
  • Flu/RSV Molecular Dx Cleared for Moderate-Complexity Labs
    It requires no nucleic acid extraction procedure and generates results within an hour. A CE mark was granted in 2011. Focus (a subsidiary of Quest Diagnostics) says the Simplexa ...
    10-10-2012
  • Quest Nabs Rheumatoid Arthritis Biomarker
    Quest Diagnostics and Augurex Life Sciences inked an exclusive license agreement centered on the development of a clinical laboratory-developed testing service for the U.S. market ...
    10-10-2012
  • Drawing Out Cancer With Biomarkers
    ... In late 2009, the FDA approved OVA1 (Vermillion and Quest Diagnostics), a 5-protein serum assay for ovarian tumor malignancy. Genetic tests for risk factors have become more ...
    9-5-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll